Smoking, coffee intake, and Parkinson's disease: Potential protective mechanisms and components

被引:0
作者
Hong, Sa Weon [1 ]
Page, Rachel [1 ]
Truman, Penelope [1 ]
机构
[1] Massey Univ, Sch Hlth Sci, Wellington 6021, New Zealand
关键词
Parkinson's disease; Smoking; Coffee drinking; Phenolic compounds; Monoamine oxidase B; Catechol O -methyltransferase; CATECHOL-O-METHYLTRANSFERASE; MONOAMINE-OXIDASE-B; 6-HYDROXYDOPAMINE RAT MODEL; NRF2 TRANSCRIPTION FACTOR; NF-KAPPA-B; ALPHA-SYNUCLEIN; CAFFEIC ACID; OXIDATIVE STRESS; FERULIC ACID; MOUSE MODEL;
D O I
10.1016/j.neuro.2024.12.003
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Parkinson's disease (PD) is a common progressive neurodegenerative disease characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc). Environmental and lifestyle factors, such as smoking and coffee drinking, have been associated with a decreased risk for PD. However, the biological mechanisms underlying protective effects on PD are still not fully understood. It has been suggested that nonnicotine components in cigarette smoke and non-caffeine components in coffee may contribute to this protective effect. The aim of this review was to explore candidate molecules and mechanisms behind the effects of smoking and coffee drinking on PD by integrating findings from previous studies. By cross-referencing an index of tobacco constituents and a list of coffee constituents with existing literature on natural compounds and their structural analogs that show inhibitory activities against monoamine oxidase B, catechol O-methyltransferase, and alpha-synuclein fibrillation, we have identified tobacco and coffee components that inhibit these targets. Furthermore, tobacco and coffee components potentially play roles in suppressing neuroinflammation, activating the Nrf2 pathway as natural activators, and altering the gut microbiome. This review suggests that the phenolic compounds from tobacco and coffee investigated may contribute to the low incidence of PD in smokers and coffee drinkers, showing moderate to strong potential as therapeutic interventions. The current review suggests that multifunctional molecules found in coffee and cigarette smoke may have potential neuroprotective effects, but none of the data indicates that multifunctionality is required for these effects. This review will deepen our understanding of how smoking and coffee drinking are linked to a reduced risk of PD and will also be important in elucidating the mechanisms underlying the protective effects of smoking and coffee drinking on PD.
引用
收藏
页码:48 / 63
页数:16
相关论文
共 50 条
  • [21] Ferroptosis in Parkinson's disease: Molecular mechanisms and therapeutic potential
    Ding, Xv-shen
    Gao, Li
    Han, Zheng
    Eleuteri, Simona
    Shi, Wei
    Shen, Yun
    Song, Zi-yao
    Su, Mingming
    Yang, Qian
    Qu, Yan
    Simon, David K.
    Wang, Xue-lian
    Wang, Bao
    AGEING RESEARCH REVIEWS, 2023, 91
  • [22] Dietary Fat Intake and Risk for Parkinson's Disease
    Dong, Jing
    Beard, John D.
    Umbach, David M.
    Park, YikYung
    Huang, Xuemei
    Blair, Aaron
    Kamel, Freya
    Chen, Honglei
    MOVEMENT DISORDERS, 2014, 29 (13) : 1623 - 1630
  • [23] Coffee, smoking and aspirin are associated with age at onset in idiopathic Parkinson's disease
    Gabbert, Carolin
    Koenig, Inke R.
    Lueth, Theresa
    Kolms, Beke
    Kasten, Meike
    Vollstedt, Eva-Juliane
    Balck, Alexander
    Gruenewald, Anne
    Klein, Christine
    Trinh, Joanne
    JOURNAL OF NEUROLOGY, 2022, 269 (08) : 4195 - 4203
  • [24] Linking Smoking, Coffee, Urate, and Parkinson's Disease - A Role for Gut Microbiota?
    Scheperjans, Filip
    Pekkonen, Eero
    Kaakkola, Seppo
    Auvinen, Petri
    JOURNAL OF PARKINSONS DISEASE, 2015, 5 (02) : 255 - 262
  • [25] Coffee, smoking and aspirin are associated with age at onset in idiopathic Parkinson’s disease
    Carolin Gabbert
    Inke R. König
    Theresa Lüth
    Beke Kolms
    Meike Kasten
    Eva-Juliane Vollstedt
    Alexander Balck
    Anne Grünewald
    Christine Klein
    Joanne Trinh
    Journal of Neurology, 2022, 269 : 4195 - 4203
  • [26] The potential of natural products to inhibit abnormal aggregation of α-Synuclein in the treatment of Parkinson's disease
    Yang, Kaixia
    Lv, Zhongyue
    Zhao, Wen
    Lai, Guogang
    Zheng, Cheng
    Qi, Feiteng
    Zhao, Cui
    Hu, Kaikai
    Chen, Xiao
    Fu, Fan
    Li, Jiayi
    Xie, Guomin
    Wang, Haifeng
    Wu, Xiping
    Zheng, Wu
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [27] Fluorescent probes for bioimaging of potential biomarkers in Parkinson's disease
    Gao, Liqian
    Wang, Wei
    Wang, Xuan
    Yang, Fen
    Xie, Liuxing
    Shen, Jun
    Brimble, Margaret A.
    Xiao, Qicai
    Yao, Shao Q.
    CHEMICAL SOCIETY REVIEWS, 2021, 50 (02) : 1219 - 1250
  • [28] PARkinson's: From cellular mechanisms to potential therapeutics
    Lengyel-Zhand, Zsofia
    Puentes, Laura N.
    Mach, Robert H.
    PHARMACOLOGY & THERAPEUTICS, 2022, 230
  • [29] The Therapeutic Potential of Hydroxycinnamic Acid Derivatives in Parkinson's Disease: Focus on In Vivo Research Advancements
    Yang, Lan
    Nao, Jianfei
    Dong, Xiaoyu
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2023, 71 (29) : 10932 - 10951
  • [30] Neuroprotective role of coconut oil for the prevention and treatment of Parkinson's disease: potential mechanisms of action
    Deepika, N. P.
    Kondengadan, Mohammed Shameer
    Sweilam, Sherouk Hussein
    Rahman, Md. Habibur
    Muhasina, K. M.
    Ghosh, Puja
    Bhargavi, Divya
    Palati, Divya Jyothi
    Maiz, Fathi
    Duraiswamy, B.
    BIOTECHNOLOGY AND GENETIC ENGINEERING REVIEWS, 2022, 40 (04) : 3346 - 3378